Prevounce Health, a leading provider of remote care management software, devices, and services, announces that patients have now transmitted more than 15 million vital readings using the company’s Pylo remote monitoring devices.
Pylo remote monitoring devices include blood pressure monitors, weight scales, blood glucose meters, and pulse oximeters. Each is clinically validated, comes with 5G/4G-LTE cellular connectivity, and seamlessly transmits readings to the Prevounce remote care platform or third-party platforms via API connectivity.
Patients use Pylo devices to collect and securely transmit health data like blood pressure, weight, blood glucose, oxygen saturation, and pulse rate readings to their care teams. With this data, providers can identify potential health issues early and intervene promptly, preventing potential hospitalizations. Pylo RPM devices also help patients take greater ownership of and better engage in their health through the ongoing monitoring of vital signs, leading to better self-care practices.
Providers with RPM programs are increasingly choosing Pylo devices for their patients. Each device is clinically validated, highly secure, and was designed for patient ease of use. In addition, the devices’ cellular coverage with automatic 2G fallback guarantees wider network coverage, better ensuring data from patients — even those in rural and more remote areas of the country — successfully reaches care teams.
“Achieving 15 million vital sign transmissions with Pylo devices reflects how connected care is transforming healthcare,” says Lucy Lamboley, Vice President of Operations at Prevounce. “Every data point represents a patient receiving proactive, real-time support — helping avoid complications and improve outcomes. This milestone reinforces the power of seamless, reliable remote monitoring to make care more accessible and effective. It’s also a testament to the commitment of the entire Prevounce team to delivering solutions and services that help improve the health of patients and success of providers.”
When Pylo remote monitoring devices are paired with the Prevounce platform, their value is enhanced. Data from the devices automatically feeds into each patient’s profile, enabling providers to easily monitor vitals and chart patient progress over time. This data can also be fed into integrated electronic health record platforms, enabling Prevounce-powered remote care programs to fit seamlessly into existing clinical and billing workflows.
“We take great pride in this vital signs milestone, but our sights are set even higher,” says Lamboley. “Over the past 12 months, Prevounce has experienced a remarkable surge in the adoption of our devices and platform. We now have about 77,000 devices deployed and our platform receives about 800,000 patient readings a month. As we continue onboarding more practices and health systems, we anticipate these figures to grow exponentially in the year ahead.”
